Sodium intake is associated with cardiovascular disease (CVD) only in communities where the average intake is more than five grams per day, according to an update of the Prospective Urban Rural Epidemiology (PURE) study published in The Lancet.

Harvard scientist Sekar Kathiresan, MD, believes polygenic risk score could help identify people at high risk for heart attack. Kathiresan, director of the Cardiovascular Disease Initiative at the Broad Institute and a professor at Harvard Medical School, said polygenic risk scores, based on genetic testing, will be as commonly known as cholesterol levels. 

Estrogen may protect against heart failure (HF)-related depression by preventing the creation of inflammation-causing chemicals in the brain, according to research published in the American Journal of Physiology.

The FDA has approved migalastat, the first oral medication for the treatment of adults with Fabry disease, the agency announced Aug. 10.

A 45-year-old man who had a stroke now creates “eye-catching” pictures—a talent he didn’t have before the medical emergency. Wayne Sheppard of the United Kingdom now sells some of his paintings for up to $510 (or £400).

Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy.

Home-delivered sodium-restricted Dietary Approaches to Stop Hypertension (DASH/SRD) meals after heart failure (HF) hospitalizations appeared safe in some patients, has the potential to improve HF symptoms and can reduce readmissions, according to new research in Circulation: Heart Failure.

Investor’s Business Daily published a profile of Johns Hopkins physician Helen Brooke Taussig, MD, who overcame an initial rejection to medical school due to gender discrimination and went on to create the field of pediatric cardiology.